Allarity Therapeutics Inc (ALLR) Financials

$1.26

$0.00 (-0.17%)

As on 10-Sep-2026 14:59EDT

Market cap

$23 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.35	0.32	--	--	--	--
Cost of Revenue	-0.03	--	0.01	0.04	0.12	0.11
Gross Profit	0.37	0.32	-0.01	-0.04	-0.12	-0.11
Operating Expenses	11.17	12.93	27.24	17.13	34.46	26.56
Operating Profit (EBIT)	-10.80	-12.61	-27.24	-17.13	-34.46	-26.56
Other Income	--	--	--	--	16.88	--
Profit before Tax	-12.33	-11.23	-24.90	-11.82	-17.58	-26.52
Provision for Tax	--	--	-0.38	0.08	-1.52	0.13
Profit after Tax (Net Income)	-12.33	-11.23	-24.52	-11.90	-16.06	-26.65
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-21.05	-26.65

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	3.54	9.83	11.81	-2.75	1.89	18.78
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	0.45	1.43	10.13
Current Liabilities	28.58	8.43	10.84	14.17	11.22	20.72
Total Liabilities	60.69	18.26	22.65	11.86	14.54	49.63

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.39	0.33	0.31	9.89	9.58	28.23
Current Assets	31.73	17.93	22.34	1.97	4.97	21.40
Total Assets	60.69	18.26	22.65	11.86	14.54	49.63
Total Debt*	22.29	1.40	1.35	1.30	3.74	1.09
Net Current Assets	3.15	9.50	11.50	-12.20	-6.25	0.34

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-14.82	-17.35	-12.75	-16.82	-15.05
Cash Flow from Investing Activities	--	-0.01	-0.30	--	0.79	1.00
Cash from Financing Activities	--	10.65	36.79	11.00	-1.31	33.82
Net Cash Inflow / Outflow	--	--	--	--	-17.34	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.81	-0.78	-15.56	-2,428.78	--	--
Cash EPS ($)	--	-0.78	-15.55	-2,422.65	--	--
Adjusted Book Value ($)	--	0.68	7.50	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.03	-11.01	-2,601.02	--	--
Free Cash Flow per Share ($)	--	-1.03	-11.20	-2,601.02	--	--

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-92.10	-418.70	-570.24	-125.97	-109.87
ROE (%)	-184.59	-103.80	-541.17	2,764.46	-155.34	-116.79
ROA (%)	-27.13	-54.91	-142.07	-90.14	-50.04	-64.18
EBIT Margin (%)	-2,488.12	-3,447.81	--	--	--	--
Net Margin (%)	-3,575.07	-3,509.69	--	--	-95.11	--
Cash Profit Margin (%)	0.13	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	5,650.00	--	--	--	--	--
EBIT Growth (%)	64.64	54.49	-114.16	34.78	32.92	-324.25
Net Profit Growth (%)	48.81	54.19	-105.99	25.89	39.74	-303.64
EPS Growth (%)	94.48	0.95	0.99	--	--	--
Book Value Growth (%)	-71.61	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.38	-0.08	0.00	--	--
Price / Book Value	6.39	1.58	0.16	0.00	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.08	-0.20	0.68	-0.10	-0.10	0.73
Close Price ($)	1.29	1.08	1.17	16.53	12,339.60	435,729.00
High Price ($)	2.35	2.35	152.70	19,740.00	540,019.20	764,400.00
Low Price ($)	0.77	0.61	0.90	12.03	8,866.20	360,213.00
Market Cap ($ Cr)	22.59	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.14	0.11	-0.47	1.98	0.06
Short term debt to equity ratio	6.30	0.14	0.11	-0.47	1.41	0.01
Current Ratio	1.11	2.13	2.06	0.14	0.44	1.03
Quick Ratio	1.11	--	--	--	--	1.10
Interest Coverage	-10.59	-59.64	-37.13	-22.73	-77.83	-40.43

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	379.71	279.69	--	--	--	--
Asset Turnover	0.01	0.02	--	--	--	--
Receivable days	--	1,782.88	--	--	--	--
Inventory Days	--	--	--	--	-4,093.84	-4,634.54
Payable days	--	--	255,634.42	72,393.54	10,575.51	4,848.18
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.